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Primary and Secondary Risk Factors for
Birth Defects
by K. Lemone Yielding
Birth defects maybe inherited in the germ line or mayresultprimarilyfrom awide spectrum ofpredictable
physical, chemical, and infectious processes that can operate in the mother, the father, or in the zygote. The
systematic consideration ofthese mechanisms can lead to a fresh awareness of risk and possible strategies
toward recognizing and avoiding such risks. Birth defects also depend heavily on secondary factors that may
even be of greater concern than any single primary insult because they may simultaneously affect the
consequences of more than one primary exposure. Under the influence of secondary factors, the frequency,
timing, and intensity of developmental deficiencies can be quite varied. It is particularly interesting that
expression can be delayed until quite late in life, and deficiencies mayoccurorbe expressedonlyin responseto
the appropriate environmental stress or functional demand. Any discussion of teratogenic mechanisms,
therefore, is not complete without taking into account the important concept of co-teratogenesis, or the
operation of secondary risk mechanisms. The principle of secondary risk or co-teratogenesis has been
demonstrated by means of enhancement of radiation-induced terata by the administration of drugs that
inhibit DNA repair. An example of late-onset expression of prenatal damage was illustrated with postnatal
retinal degeneration occurring after prenatal damage to the developing retina. It is suggested that a
systematic consideration ofprimaryand secondary risk mechanisms can leadto abetterunderstandingofthe
problem ofbirth defects.
Introduction
The purpose of this paper is to provide an overview of
birth defects and their relationship to environmental
insults. Such a discussion, ifjoined widely by environmen-
tal and biomedical scientists, can result in more coordi-
nated and effective approaches to the prevention of
environmentally provoked abnormalities through better
understanding of the nature and management of risk
resulting from exposure to either natural or man-made
factors. Birth defects, of course, represent a restricted
subset of significant toxic events targeting the conceptus
that do not result in immediate death but still permit some
progression of the developmental processes. In fact,
failure ofsurvival ofthereproductive productmustalsobe
considered as a possible result of the same processes as
those discussed here. This discussion emphasizes two
major points: First, birth defects result from a wide
spectrum ofpredictable physical, chemical, and infectious
processes that can operate in themother, the father, orthe
zygote. The systematic consideration ofthesemechanisms
can lead to a fresh awareness of risk and possible strat-
egies toward recognizing and avoiding such risks.
Second, the causes and expression schedules of birth
defects depend heavily on secondary factors as well as
primary mechanisms of damage. In fact, secondary fac-
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tors may even be of greater concern than any single
primaryinsultbecausetheymaysimultaneouslyaffectthe
consequences of more than one primary exposure. The
discussion ofsecondaryfactors shouldbeprefacedbyfour
generalizations: a) The outcomes for perturbations ofthe
developmental processes are dictated by the basic critical
vulnerabilities ofthe targeted systems; b) the timing and
intensity ofdevelopmental deficiencies can be quitevaried
(immediate, delayed, subtle, mild, severe, or latent), with
resulting great increases in the time ofvulnerabilities for
compromised structure and function; c) expression of
developmental deficiencymayoccuronlyinresponsetothe
appropriate environmental stress or functional demand;
and d) any discussion of teratogenic mechanisms, there-
fore, is not complete without taking into account the
important concept ofco-teratogenesis, or the operation of
secondary risk mechanisms. The following is a general
rexiew of these principles and some brief illustrations of
some ofthe concepts from our own work.
Classification of Birth Defects in
Relation to Prevention Strategies
"Birth defects" may be defined as abnormalities of
biological form and/or function resulting from abnormaV
incomplete differentiation and development. "Teratogene-
sis" generally is used to refer to the processes involved in
development of such abnormalities. Birth defects can beK L. YIELDING
classified in a number of different ways, and the use of
different schemes has led to some general confusion about
causes andmechanisms. Themostimportantconsequence
of any approach to the general subject is clarity in our
thinking about howwe can prevent ormodify the severity
ofsuch phenomena.
Inherited Birth Defects
Defects that are simply passed along in the germ line
from either parent are classified as inherited defects or
deficiencies. These defects, according to the principles
stated above, can be large anatomical defects or simple
enzyme/metabolic defects; theymaybeexpressedimmedi-
ately at birth or may be delayed in expression until much
laterinlife; ortheymaynotevenbedetecteduntilorunless
the individual is stressed appropriately. Furthermore, the
extent or nature of their expression may depend on the
additional genetic makeup of the individual. In many
instances defects may even be considered as "normal
variants."
It is particularly interesting to consider those defects
and diseases that are not detected at birth and whose
consequences are delayed and appear progressively in
postnatallife. These diseases are notuniformintheageof
onset nor in the severity of the resulting disease man-
ifestations, suggesting a potential role of environmental
factors. Mechanistically, expression depends on time and
the environment in specific ways, and better understand-
ing ofthese facts can lead to control strategies. The hope
ofmoderngenetechnologyisthatsomedeficiencies canbe
corrected directlyby supplying the genes for the missing
proteins. Even without success with such innovative tech-
niques, it may still be possible to modify the outcome by
otherspecific rational approaches. When anessential syn-
thetic enzymeisdeficient, itmaybepossible toprovidethe
essential product through direct supplementation or to
activate or stimulate alternative metabolic pathways. In
the case of defects in catabolic enzymes or enzymes that
eliminate toxic metabolic intermediates, the time of dis-
ease development depends on the kinetics of the system
because there must be sufficient time to allow accumula-
tion of the corresponding metabolic product(s). Control
could take the form of decreasing the synthesis of the
precursor ofthe product through targeted metabolic con-
trol, preventing exposure to precursors from the environ-
ment, or by activating alternative degradative pathways.
When degenerative changes are involved, time and
molecularturnovermustoccurtogeneratethedeficiencies
that account for losses in function. In this instance the
therapeutic or preventive objectives could be met by
decreasing turnover through stabilizing the target mole-
cules orbystimulatingsyntheticandreparativeprocesses.
Furthermore, abnormal synthetic processes may not be
activated and become significant until the appropriate
levelofmaturityisachievedthatrequires theexpressionof
the corresponding synthetic process. This may allow for
therapeutic interference with the activation of the tar-
geted process. Degeneration or toxic manifestations may
not occur until the appropriate stress or demand condi-
tions are presented to trigger evidence of defective func-
tion, providing the opportunity to intervene through
understandingandcontrollingsuchstress. Itisimportant,
therefore, to recognize that there are environmental and
temporal constraints and influences on the expression of
inherited birth defects. Through recognition of the full
spectrum of primary and secondary risk factors, both
intrinsic and environmental, it should be possible to mod-
ify the occurrence and expression of many such defects.
Themainpointtobemadeisthateventheclassicinherited
type ofbirth defect or genetic disease can be sensitive to
environmental manipulation and should be ofgreat inter-
est and concern to the environmental scientist.
Acquired Birth Defects
Thebirth defectsthathaveattracted themostattention
ofenvironmental scientists are those that may be consid-
ered asacquiredorinflictedthroughtheactionofphysical,
chemical, or infectious agents in the environment. These
may be further subdivided into three groups.
First, abnormalities may result from events that com-
promise theinformationprovidedbyeitheroftheparental
germ cells at somepointbefore fertilization. This recogni-
tionthatthedifferentiation processisvulnerable to events
thatimpingeoneitherparentisessentialtounderstanding
environmental risk and contrasts with the historical ten-
dency to consider as targets only the developing zygote
and/or the egg. Thus, either germ cell may acquire a new
mutation, there may simply be maldistribution of genes
and organelles during the processes ofcell division (both
reductive and nonreductive), or maturation can be dis-
rupted. It is interesting to contrast the possible dif-
ferences in targeting male and female germ cells in
mammals, in view of the fact that stem cells continue to
yield progeny throughout reproductive life of the male,
whereas in the female, differentiation is essentially com-
plete prenatally, and only final reductive divisions and
maturation of the egg occur in the adult mammalian
female. This means that male and female germ cells may
differ greatly in their susceptibility to damage and their
ability to repair and recover. Moreover, the long-term
consequences from mutations of gamete stem cells in
mature males contrasts with those from mutations in the
differentiated gamete inthematurefemalebecause, inthe
stem cell, a mutation may influence multiple reproductive
events rather than a single mature gamete.
There is a general tendency in thinking about muta-
tionalcausesofbirthdefectstolookforspecificsyndromes
or complexes of abnormalities. This is taking the most
specific and restricted view ofdifferentiation: that abnor-
malities of a single system can only arise from a few
mutations in alimited numberofgenes, such as those that
directly control the sequence of development. However,
whendevelopmentisconsidered as abalancedassemblyof
processes, functions, and cell interactions, itis easyto see
that even in relation to differentiation and function of a
speciflc organ system alargevarietyofmutations couldbe
expected to have an influence, and each, if it survived,
could result in a different slate of defects. It may be
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fallacious, therefore, to look for specific developmental
syndromes associated with specific mutagenic actions and
agents.
The female gamete has an additional vulnerability over
that ofthe male because ofthe factthatthemitochondrial
genome of the zygote is contributed entirely by the egg.
This is complicated further by the fact that mitochondria
are not equipped with the same DNA repair mechanisms
as the nucleus. It is not possible to assign the relative
frequency of teratogenic events that arise from compro-
miseofthegermcells,butawareness oftheirvulnerability
is essential to any prevention strategies.
Second, any significant compromise of the zygote can
result in developmental disruption. Insults may be in the
form of damage to DNA, maldistribution of genes and
organelles during fertilization and subsequent cell divi-
sion, criticalchangesincellnumbers arising outofmodifi-
cation in cell division and turnover, or interference with
membrane transport, metabolism, metabolic control, and
othernormalregulatoryprocesseswithinthezygote(cell-
cell communication, and autocrine, endocrine, and neural
control generally). Furthermore, the zygote is vulnerable
to physical perturbations such as mechanical pressures
during differentiation, as well as a large number of
unknown infections. When changes in the DNA are
involved, these may be termed, in the broadest context,
somatic cellmutation. However,itmustbeunderstoodthat
it does not follow that persistent genetic changes will be
detectableinthesurvivingcells ofthezygote,indeed, even
in abnormal organs. The mutated cell(s) simply may not
survive, and the zygote maybe compromised in its ability
to develop fully and correctly.
Third, highly differentiated animals depend on very
specific functioning and relationships with the support
structures in the placenta (or the yolk sac in nonplacental
animals). Thus, anydisruptionwiththeorderlyand appro-
priate exchange of gases, nutrients, and waste materials
either on the maternal side or at the zygote can lead to
significant fetotoxicity.
Attention mustbe focused, therefore, on the germ cells,
thezygote, andtheplacentainacomplete discussion ofthe
causes and management ofacquired birth defects. These
generalizations are summarized in Table 1.
Table 1. Types ofbirth defects
(anatomical or biochemical/functional deficiencies).
Inherited
Expression immediate, delayed, or latent
Expression may depend on additional genetic makeup
Expression may depend on stress or other environmental factors
Timing and contingency ofexpression provides opportunity for inter-
vention
Acquired
Insults to germ line cells
Mutations and maldistribution ofgenes and organelles
Interference with maturation
Insults to zygote
Mutations and maldistribution of genes and organelles during and
subsequent to fertilization
Influences on cell numbers and survival
Regulation ofcell and tissue processes
Interference with placental function
Targets for Teratogenic Insults
Leading to Acquired Birth Defects
The general targets for teratogenic insults are summa-
rized in Table 2. Undoubtedly, DNA is the most effective
target of all. It is the largest unique molecule in the cell,
and has extremely low copy numbers for most of its
functions. It is both accessible and chemically reactive. It
has hydrophobic regions to bind nonpolar ligands, is a
highly ordered polyelectrolyte with extensive opportunity
toreactwithcharged species, anditpresents,forreaction,
electrophiles, nucleophiles, and aromaticrings. Because of
its central information role, rare lesions can be amplified
into large biological events, and lesions can be stored for
later expression. DNA damage is the most predictable
embryotoxic mechanism. It would be expected, therefore,
that agents known to be mutagens or to interact signifi-
cantly with DNA to modify expression should be very
suspect as potential teratogens. It is perhaps fortunate
that significant damage to the genome probablyresults in
a nonviable zygote.
DNA is a complicated target for a number of reasons.
For aspecific structural gene, the consequences ofaltera-
tion are straightforward, ranging from complete abroga-
tion of function to changes in efficiency, specificity,
regulation, orothercharacteristicsoftheresultingbiolog-
ical roles. For a regulatory gene, alteration may result in
loss ofnormalregulatorycontrol, an eventofgreatsignifi-
cance to the process of differentiation. In addition, vast
sequences ofDNA are noncoding in the usual sense, and
the results of small changes in structure are unknown.
Furthermore, thereexistinmostcellshighlyactiverepair
systemswhose function is to restore the structural integ-
rity of DNA. Although these would seem to be of great
importanceinpreservingthedifferentiation process, their
precise roles in eitherthe germ cells orthe zygote are not
known. Despite these complexities, DNA may be pre-
sumed tobe animportanttargetin assigningrisks during
differentiation. Presumably, the consequences of damage
depend, among other things, on the developmental stages
of the targeted cells and the recovery potential through
molecularrepair,simplecellreplacement, andtissuerepair
and remodeling. The roles forexpression ofviral genomes
or theirinterference with normal expression must also be
considered in any discussion of such nucleic acid targets.
In additiontotheinformation system, the requirements
for structural and functional integrity suggest several
additionalclasses oftargets. Clearly, anydisruption ofcell
organelles andtheir structural moleculeswouldbe critical
to both germ cells and the zygote. Similarly, cytoskeletal
Table 2. Targets for teratogenic insults.
DNA: single most effective target
Organelles and their structural molecules
Cytoskeletal proteins
Critical catalytic proteins
Regulatory molecules
Extracellular structural macromolecules
Membranes and transport proteins
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proteins are critical to the structural integrity of both
cells and tissues. Critical catalytic proteins (enzymes,
contractile and transport proteins) are also essential. In
the case of the zygote, both extracellular structural pro-
teins and regulatory molecules play vital roles in differ-
entiation and in establishing and maintaining structure.
Thus, it is apparent that a series ofpotential targets may
readily be identified from which damaging interactions
may be translated into the development of birth defects.
Targets for the Sites and Mechanisms
ofAction ofSecondary Risk Factors
Understanding the fact and the mechanisms for opera-
tion of secondary risk factors in the genesis of birth
defects is possibly of even greater importance than the
recognition of single primary risk mechanisms. First of
all, the action of any primary insult can be influenced
drasticallybythe action ofotherfactors, up to andinclud-
ingthepossibilitythataspecific primaryinsultmayresult
in birth defects only when coupled with the appropriate
secondaryconditions. Second, a secondaryriskfactormay
simultaneously influence the consequences ofexposure to
multiple primary insults. A secondary mechanism, there-
fore, may amplify the effects either of multiple, primary
environmental exposures or intrinsic deficiencies which if
encountered alone might not have significant conse-
quences. Finally, it should be emphasized that almost all
attempts to recognize risk simply look for evidence of
reproductive and developmental toxicitywithout consider-
ing the effects of any secondary risk mechanisms or
possible effects of new agents on the ability of other
preexisting primary risk factors to cause birth defects.
Although ourconsideration ofsecondaryriskfactorsorco-
teratogenic mechanisms is very primitive, it is quite rea-
sonable tothinkoftheprocess in terms ofpossible targets
and putative mechanisms. Table 3 provides a list ofpoten-
tial "co-teratogenic" mechanisms for discussion. In addi-
tion to these classes ofenvironmental effects, it must also
be remembered that host susceptibility to both primary
and secondary risk factors may vary considerably due to
Table 3. Coteratogenetic mechanisms.
Mechanisms directed at offending agent ("dose" ofultimate insult)
Environmental processing and availability
Absorption
Excretion
Binding
Metabolism
Mechanisms involving target for the insult
Accessibility
Number
Expression
Mechanisms affecting on response patterns
Kinetics, demand, and accessibility ofprimary and interrelated func-
tional systems
Effects on recovery
Molecular repair
Cell replacement, proliferation, and tissue recovery
genetically determined differences in the targeted indi-
viduals.
Thefirstcategoryofco-teratogenicmechanismincludes
allthosethatexerttheireffects ontheprimaryagentitself
and its bioavailability in active form for presentation to
relevant targets. In the temporal, sense, these are the
factors that operate before the teratogenic insults. These
include such processes as metabolic or chemical activation
ordeactivationintheenvironment; influences onexposure,
absorption, excretion, transport, and thus bioavailability
in the target subject; and metabolic activation and
inactivation in the exposed subject.
All these effects can be considered dose-modifying
effects.Thereare,infact, quiteinterestingandpredictable
consequences for such effects. In the case of chemicals
released into the environment, it may be of major impor-
tance to consider the consequences of transformation
eithertoinactive substances orfrombiologicallyinertinto
biological hazardous substances. Figure 1 illustrates a
rather graphic example ofthe sort ofconcern that should
be faced when releasing material into the environment.
Thalidomide, as shown, is aphthalamide derivative that is
a potent human teratogen. Also shown are examples of
phthalmide pesticides that have been released into the
environment in millions oftons. Fortunately, no biological
or chemical transformation has occurred in the environ-
ment to result in an active phthalamide teratogen. How-
ever, this is the type ofsituation inwhich complete consid-
Thalidomide
000 O N
Phthalamide dimer
0
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0 0
NIN
0 0
Folpet
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FIGURE 1. Comparison of the structures of thalidomide, a teratogenic
dimeric derivative of thalidomide, and certain phthalamide-derived
pesticides.
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eration of risk mechanisms could suggest appropriate
tests before release.
The evidence is much more compelling that chemical
compounds can significantly influence the bioavailability
ofactive forms ofother agents through effects on activat-
ing or inactivating drug-metabolizing enzymes or drug-
conjugating enzymes in the targeted host. Such effects
from dietary intake, environmental exposure, or drug
administration have been discussed extensivelyin relation
to carcinogenic chemicals and drugs in general but have
not been emphasized extensively for their relevance to
teratogenesis. Sucheffects areexcellentexamples ofhowa
single secondary agent can influence the biological effects
ofexposure to avariety ofother agents. Alternatively, itis
is easy to see how such an effect on drug-metabolizing
enzymes could result in conversion ofinsignificant effects
ofbackground chemicals into newbiological consequences
such as detectable levels ofteratogenesis.
Secondaryeffects ontargetsandtheirfunctionmayalso
be important. For example, where specific receptors are
involved, any secondary process that regulates receptor
numberandavailabilitycouldinfluencetheeffectiveness of
a primary insult. Enhanced risk may also result from
simultaneous exposure to two agents that affect parallel
targets representing processes that serve interrelated
functions.
Thelastmajor categoryofco-teratogenic effects occurs
after damage and includes all of the possible recovery
processes. The first type of recovery is molecular repair
such as in DNA after avariety oftypes ofdamage. Thus,
lesions in DNAthat are putatively lethal ormutagenic are
simply converted back to normal DNA sequences through
a series ofenzymic steps. Just as a single DNAlesion can
be amplified enormouslyduringbiological expression, pre-
vention of repair of a single DNA lesion by exposure to
some secondary risk factor can have an enormous influ-
ence onteratogenic consequences ofDNAdamage. This is
particularlyinterestinginlightofthebackground rates of
DNAdamage that occur as aconsequence ofmetabolicby-
products, irradiation, natural chemicals, etc. Thus, a
powerful inhibitor ofDNArepair could have the apparent
effectofcausingbirthdefects orofenhancingtheeffectsof
other gene-damaging agents. Other types of molecular
repair, such as membrane assembly and reassembly, may
also have biological reality at some level, and could be
targets for secondary effects. Recovery from injury also
includes the processes of cell turnover and replacement,
which can also be vulnerable to secondary risk factors.
The conclusion to be drawn from these discussions is
that any consideration of environmental risk must take
into account the effects of a variety of secondary risk
mechanisms. In the case of environmental teratogenesis,
the concept of co-teratogenesis must be given at least
equal attention, while for inherited birth defects,
expression may be determined by environmental factors
operating through some of these same mechanisms. The
excitement of these insights is that strategies may be
possible that can lead to prevention ofexpression ofboth
acquired and inherited defects through appropriate
manipulation ofsecondary factors.
Modeling Environmental Co-
Teratogenesis: Effects of Putative DNA
Repair Inhibitors
Some years ago, our laboratory explored the concept of
co-teratogenesis through theuse ofprenatalionizingirra-
diation in conjunction with putative DNArepairinhibitors
(1). These experiments were based on the observations
that such irradiation and the resulting DNA damage
predictablyledto anarrayofbirth defectswhoseformand
severitywereverysensitiveto doseandthegestationtime
at treatment. We had also observed that the amino-
quinoline antimalarial, chloroquine, and caffeine could
inhibit DNA repair in vitro and could enhance X-ray
lethalityinmice.Wereasoned, therefore, thatinhibitors of
repairmight be used to enhance the teratogenic effects of
irradiation or other types of DNA damage.
The experiments performed used standard methods of
timed pregnancies and radiation exposures and assayed
for cleft palates. Three findings were documented. First,
chloroquine and caffeine alone were not teratogenic over
the specific time schedule of these experiments, even at
doses that were severely toxic to the mother. Second,
chloroquine and caffeine administered afterX-irradiation
enhancedby4-foldthenumberofcleftpalatesproduced(1)
over those from X-rays alone. Parallel experiments per-
formed with neutron irradiation, which, in contrast to
X-irradiation, produces nonrepairable double-stranded
DNA strand breaks, resulted in no enhancement by con-
comitant chloroquine and caffeine administration
(unpublished observations). Third, additional experiments
usingcytoxan astheteratogenicinsultalsoshowed similar
enhancing effects ofthe chloroquine administration.
Although it can onlybe suggested circumstantiallythat
the effect of the chloroquine was through inhibition of
DNArepair, it maybe concluded that enhancement ofthe
teratogenic effects of irradiation and alkylation damage
did occur in this mouse test system by some mechanism.
Chloroquine and caffeine, therefore, acted as co-
teratogens with irradiation. A question to be addressed is
the role of the regulation of DNA repair mechanisms in
determiningpossible effects on differentiation ofthe DNA
damagethatisoccurringcontinuallyunderambientcondi-
tions even without the imposition of an acute external
perturbation. While an additional slight change in the
extentofDNAdamageresultingfrom an acute, externally
applied insult might not be significant, a change in the
ability of the organism to repair intrinsic damage might
result in the production of abnormalities. In such a sce-
nario,theco-teratogenicmechanismwouldbethedriverof
the biological consequences. Asystematic consideration of
such mechanisms could be very important.
Dose Effects of a Direct-Acting
Alkylating Agent Administered Late in
Pregnancy: Discovery of a Late-Onset
Model of a Birth Defect
For additional studies of teratogenesis through DNA
damage, it was desirable to develop a model with a defin-
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able chemical lesion on the DNAinserted on precise time
schedule and involving tissues sufficiently accessible for
biochemicalexperiments. Forthesereasons,weundertook
studies of the teratogenic effects of methylnitrosourea
(MNU), a direct-acting aklylating agent. This reagent
does not require metabolic activation, in contrast to
cytoxan, and has a half-life of only a few minutes in
biological fluids. Furthermore, ithas been shown to inter-
fere substantially with the differentiation of the retina,
which occurs in the mouse beyond the day 16 ofgestation.
Thus,mouseembryos maybetreatedwithasinglepulseof
damage administered to the mother, and the embryo is
sufficiently developed to provide access to target organs
forisolation and detailed study. Itis also relativelyeasyto
evaluatemorphologicdisruptionintheretinabecauseofits
highly ordered structure.
A single high dose ofMNU (20 mg/kg) on the day 16 of
pregnancy in the mouse characteristically results in an
abnormal retina with severe rosette formation and dys-
plasia. In a questforadoselevelthatmightcauserosettes
only if accompanied by inhibition of DNA repair, we per-
formed a series ofdose titrations. Dose reduction below 5
mg/kgwas required to achieve normal development ofthe
retina. The exciting consequences ofthis series ofexperi-
ments, however,wastheobservationthatwhiletheretinas
appeared normal shortly after birth following MNU at 1
mg/kg on day 16 of pregnancy, many of these animals
exhibited progressive loss ofretinal layers throughout the
first year of life (2). Thus, MNU at low dose produced a
late-onset retinal degeneration. Itisinteresting that most
studies of teratogenic potential sirnply assess aninals at
-one time point, usually near the end ofgestation. What is
most interesting about this lesion is that the long-term
stability ofthis nondividing tissue had been compromised
by prenatal damage. Based on this sort of model, it is
possible to expand considerably our concept ofthe conse-
quences of prenatal defects. Thus, in either inherited or
acquired birth defects the possibility must be considered
that abnormalities may be expressed only at times later in
life, possible in the form of a degenerative process. When
complicated evaluation ofbehavioral consequences ofdevel-
opmental damage areincludedwithin theframework ofthis
discussion, the implications are especially far reaching.
The acquired defect with low-dose MNU, like certain
inherited defects ofthe retina and other organs, appeared
as a long-term instability and degeneration. Accordingly,
itwould seem that this process might also be sensitive to
environmental factors. In fact, the retina in the mouse, as
well as in other species, is quite sensitive to the effects of
lightirradiation duetodamagebysingletoxygen.Accord-
ingly, ourexperiments showed thatthe MNUeffect atlow
but not at high dose was very sensitive to light conditions.
We showed that rearing animals in total darkness com-
pletely prevented the degeneration, while constant
illumination caused rapid atrophy of the retinas in the
control animals aswell (3). Furthermore, itwasfoundthat
maintenance ofthe animals on high levels ofthe antioxi-
dant butylhydroxytoluene could prevent the combined
effectsofMNUandmoderateillumination (4),presumably
by scavenging singlet oxygen.
These experiments established two important points.
First, prenatal damage can produce biochemical lesions,
which even in terminally differentiated cells can result in
instabilitymanifest bypremature or accelerated degener-
ative changes late in the postnatal period. Second, and
even more exciting, is the conclusion that through an
understandingoftheexpressionfactors,itmaybepossible
to prevent the development of overt disease even in the
face ofdefects developed prenatally either from inherited
defects or from environmental damage.
Summary and Conclusions
I urge thatwe, asmedical and environmental scientists,
undertake a systematic consideration ofprimary and sec-
ondary risk mechanisms for the production of environ-
mentallyrelated diseases. Inthe case ofbirth defects, this
should be framed as a study ofboth teratogenic and co-
teratogenic mechanisms thatcontribute to theproduction
andmanagement ofbirthdefects. I urgethatthecomplete
spectrum of birth defects to be considered include late-
onset problems such as degeneration and disease suscep-
tibilitybecausedefects cannotalwaysberecognizedimme-
diately at birth either as gross anatomical or biochemical
abnormalities. It is especially important to understand
delayed expression because of the problem of relating
cause and effect and because there may be an extended
time during which there are opportunities to intervene
and prevent overt disease. This can be important forboth
inherited and acquired defects. The experimental work
reviewed isintended to serve onlyasillustrative examples.
For details, the reader is referred to the original publica-
tions.
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